An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
Tafere Mulaw Belete Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Tafere Mulaw Belete Tel +251 918045943Email mutafere@yahoo.comAbstract: Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential...
Saved in:
Main Author: | Mulaw Belete T |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/8d554f858af04c90b29dc8788b26d7cb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
by: Rouamba T, et al.
Published: (2021) -
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
by: Saghir SAM, et al.
Published: (2021) -
Glycopeptides as Potential Interventions for COVID-19
by: Demsie DG, et al.
Published: (2020) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
by: Badawi A
Published: (2020) -
N-Acetylcysteine to Combat COVID-19: An Evidence Review
by: Shi Z, et al.
Published: (2020)